These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28597731)

  • 1. New perspectives for chronic pain treatment: a patent review (2010-2016).
    Pina LTS; Gouveia DN; Costa JS; Quintans JSS; Quintans-Júnior LJ; Barreto RSS; Guimarães AG
    Expert Opin Ther Pat; 2017 Jul; 27(7):787-796. PubMed ID: 28597731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New drugs or alternative therapy to blurring the symptoms of fibromyalgia-a patent review.
    Oliveira MA; Guimarães AG; Araújo AAS; Quintans-Júnior LJ; Quintans JSS
    Expert Opin Ther Pat; 2017 Oct; 27(10):1147-1157. PubMed ID: 28665159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The need for fundamental reforms in the pain research field to develop innovative drugs.
    Nagakura Y
    Expert Opin Drug Discov; 2017 Jan; 12(1):39-46. PubMed ID: 27838932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrins: improving the therapeutic response of analgesic drugs: a patent review.
    de Oliveira MG; Guimarães AG; Araújo AA; Quintans JS; Santos MR; Quintans-Júnior LJ
    Expert Opin Ther Pat; 2015; 25(8):897-907. PubMed ID: 25960079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expert opinion on emerging drugs: chronic low back pain.
    Hsu E; Murphy S; Chang D; Cohen SP
    Expert Opin Emerg Drugs; 2015 Mar; 20(1):103-27. PubMed ID: 25519435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terpenes and derivatives as a new perspective for pain treatment: a patent review.
    Guimarães AG; Serafini MR; Quintans-Júnior LJ
    Expert Opin Ther Pat; 2014 Mar; 24(3):243-65. PubMed ID: 24387185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The appropriate treatment of chronic pain.
    Sarzi-Puttini P; Vellucci R; Zuccaro SM; Cherubino P; Labianca R; Fornasari D
    Clin Drug Investig; 2012 Feb; 32 Suppl 1():21-33. PubMed ID: 23389873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and cost-effectiveness of intradiscal methylene blue injection for chronic discogenic low back pain: study protocol for a randomized controlled trial.
    Geurts JW; Kallewaard JW; Kessels A; Willems PC; van Santbrink H; Dirksen C; van Kleef M
    Trials; 2015 Nov; 16():532. PubMed ID: 26590962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoterpenes as Perspective to Chronic Pain Management: A Systematic Review.
    Gouveia DN; Pina LTS; Rabelo TK; da Rocha Santos WB; Quintans JSS; Guimaraes AG
    Curr Drug Targets; 2018; 19(8):960-972. PubMed ID: 28699514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acylhydrazone derivatives: a patent review.
    Maia Rdo C; Tesch R; Fraga CA
    Expert Opin Ther Pat; 2014 Nov; 24(11):1161-70. PubMed ID: 25213630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New perspectives for leishmaniasis chemotherapy over current anti-leishmanial drugs: a patent landscape.
    Machado-Silva A; Guimarães PP; Tavares CA; Sinisterra RD
    Expert Opin Ther Pat; 2015 Mar; 25(3):247-60. PubMed ID: 25530084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Drugs for the Treatment of Cancer Pain: A Review of Patent Literature in 2014.
    Anderson B; Lee S; Abd-Elsayed A
    Recent Pat Anticancer Drug Discov; 2017; 12(2):169-173. PubMed ID: 28393711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giving priority to preclinical pain measures resistant to existing drugs for developing innovative analgesics.
    Nagakura Y
    Drug Dev Res; 2018 Jun; 79(4):147-156. PubMed ID: 29732584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early phase drug development for treatment of chronic pain--options for clinical trial and program design.
    Kalliomäki J; Miller F; Kågedal M; Karlsten R
    Contemp Clin Trials; 2012 Jul; 33(4):689-99. PubMed ID: 22401888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends in neuropathic pain patents.
    Maia RD
    Expert Opin Ther Pat; 2017 May; 27(5):539-546. PubMed ID: 27998196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain.
    Labianca R; Sarzi-Puttini P; Zuccaro SM; Cherubino P; Vellucci R; Fornasari D
    Clin Drug Investig; 2012 Feb; 32 Suppl 1():53-63. PubMed ID: 23389876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism-based pain management in chronic pancreatitis - is it time for a paradigm shift?
    Kuhlmann L; Olesen SS; Olesen AE; Arendt-Nielsen L; Drewes AM
    Expert Rev Clin Pharmacol; 2019 Mar; 12(3):249-258. PubMed ID: 30664364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Welfare as the goal of the analgesic pharmacotherapy accompanying biological treatment in patients with rheumatoid arthritis and ankylosing spondylitis].
    Tomasiewicz B; Hurkacz M; Jarzibowski J; Wiela-Hojeńska A
    Pol Merkur Lekarski; 2014 Nov; 37(221):274-9. PubMed ID: 25546988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in drug discovery for overcoming 'dysfunctional pain': an emerging category of chronic pain.
    Nagakura Y
    Expert Opin Drug Discov; 2015 Oct; 10(10):1043-5. PubMed ID: 26160648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.